Table 3.

Self-reported Smoking Abstinence at 6 Months (Not Biochemically Validated), By Site

ITT populationMinimally adjusted
OutcomeControl
(n = 488)
Intervention (n = 484)Relative risk
(95% CI)
p-valueDifference in risk
(95% CI)
p-value
Self-reported smoking abstinence at 6m64 (13.1%)122 (25.2%)1.92 (1.46, 2.53)<.0010.12 (0.07, 0.17)<.001
By site*:
Site 124(11.9%)
(n = 201)
48 (24.1%)
(n = 199)
2.02 (1.29, 3.17).0020.12 (0.05, 0.20).001
Site 213(15.5%)
(n = 84)
22 (26.2%)
(n = 84)
1.69 (0.91, 3.13).0940.11 (−0.01, 0.23).085
Site 39 (17.0%)
(n = 53)
13 (24.1%)
(n = 54)
1.42 (0.67, 3.03).3690.07 (−0.08, 0.22).362
Site 48 (10.5%)
(n = 76)
18 (24.3%)
(n = 74)
2.31 (1.07, 4.99).0330.14 (0.02, 0.26).024
Site 59 (18.0%)
(n = 50)
16 (32.0%)
(n = 50)
1.78 (0.87, 3.64).1150.14 (−0.03, 0.31).101
Site 61 (4.2%)
(n = 24)
5 (21.7%)
(n = 23)
5.22 (0.66, 41.32).1180.18 (−0.01, 0.36).065
ITT populationMinimally adjusted
OutcomeControl
(n = 488)
Intervention (n = 484)Relative risk
(95% CI)
p-valueDifference in risk
(95% CI)
p-value
Self-reported smoking abstinence at 6m64 (13.1%)122 (25.2%)1.92 (1.46, 2.53)<.0010.12 (0.07, 0.17)<.001
By site*:
Site 124(11.9%)
(n = 201)
48 (24.1%)
(n = 199)
2.02 (1.29, 3.17).0020.12 (0.05, 0.20).001
Site 213(15.5%)
(n = 84)
22 (26.2%)
(n = 84)
1.69 (0.91, 3.13).0940.11 (−0.01, 0.23).085
Site 39 (17.0%)
(n = 53)
13 (24.1%)
(n = 54)
1.42 (0.67, 3.03).3690.07 (−0.08, 0.22).362
Site 48 (10.5%)
(n = 76)
18 (24.3%)
(n = 74)
2.31 (1.07, 4.99).0330.14 (0.02, 0.26).024
Site 59 (18.0%)
(n = 50)
16 (32.0%)
(n = 50)
1.78 (0.87, 3.64).1150.14 (−0.03, 0.31).101
Site 61 (4.2%)
(n = 24)
5 (21.7%)
(n = 23)
5.22 (0.66, 41.32).1180.18 (−0.01, 0.36).065

*Test for interaction: p = .8191.

Table 3.

Self-reported Smoking Abstinence at 6 Months (Not Biochemically Validated), By Site

ITT populationMinimally adjusted
OutcomeControl
(n = 488)
Intervention (n = 484)Relative risk
(95% CI)
p-valueDifference in risk
(95% CI)
p-value
Self-reported smoking abstinence at 6m64 (13.1%)122 (25.2%)1.92 (1.46, 2.53)<.0010.12 (0.07, 0.17)<.001
By site*:
Site 124(11.9%)
(n = 201)
48 (24.1%)
(n = 199)
2.02 (1.29, 3.17).0020.12 (0.05, 0.20).001
Site 213(15.5%)
(n = 84)
22 (26.2%)
(n = 84)
1.69 (0.91, 3.13).0940.11 (−0.01, 0.23).085
Site 39 (17.0%)
(n = 53)
13 (24.1%)
(n = 54)
1.42 (0.67, 3.03).3690.07 (−0.08, 0.22).362
Site 48 (10.5%)
(n = 76)
18 (24.3%)
(n = 74)
2.31 (1.07, 4.99).0330.14 (0.02, 0.26).024
Site 59 (18.0%)
(n = 50)
16 (32.0%)
(n = 50)
1.78 (0.87, 3.64).1150.14 (−0.03, 0.31).101
Site 61 (4.2%)
(n = 24)
5 (21.7%)
(n = 23)
5.22 (0.66, 41.32).1180.18 (−0.01, 0.36).065
ITT populationMinimally adjusted
OutcomeControl
(n = 488)
Intervention (n = 484)Relative risk
(95% CI)
p-valueDifference in risk
(95% CI)
p-value
Self-reported smoking abstinence at 6m64 (13.1%)122 (25.2%)1.92 (1.46, 2.53)<.0010.12 (0.07, 0.17)<.001
By site*:
Site 124(11.9%)
(n = 201)
48 (24.1%)
(n = 199)
2.02 (1.29, 3.17).0020.12 (0.05, 0.20).001
Site 213(15.5%)
(n = 84)
22 (26.2%)
(n = 84)
1.69 (0.91, 3.13).0940.11 (−0.01, 0.23).085
Site 39 (17.0%)
(n = 53)
13 (24.1%)
(n = 54)
1.42 (0.67, 3.03).3690.07 (−0.08, 0.22).362
Site 48 (10.5%)
(n = 76)
18 (24.3%)
(n = 74)
2.31 (1.07, 4.99).0330.14 (0.02, 0.26).024
Site 59 (18.0%)
(n = 50)
16 (32.0%)
(n = 50)
1.78 (0.87, 3.64).1150.14 (−0.03, 0.31).101
Site 61 (4.2%)
(n = 24)
5 (21.7%)
(n = 23)
5.22 (0.66, 41.32).1180.18 (−0.01, 0.36).065

*Test for interaction: p = .8191.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close